How many studies have been conducted on Angiopoietin 2?

BiohacksAI has indexed 300 PubMed studies on Angiopoietin 2, including 6 randomized controlled trials (RCTs). 52% of studies involve human subjects.

What are the main research areas for Angiopoietin 2?

The primary research domains for Angiopoietin 2 are 🔬 Oncology, 🫘 Kidney, ❤️ Cardiovascular. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Angiopoietin 2

An angiopoietin that is closely related to ANGIOPOIETIN-1. It binds to the TIE-2 RECEPTOR without receptor stimulation and antagonizes the effect of ANGIOPOIETIN-1. However its antagonistic effect may be limited to cell receptors that occur within the vasculature. Angiopoietin-2 may therefore play a role in down-regulation of BLOOD VESSEL branching and sprouting.

300+ PubMed studies analyzed · 6 RCTs · Evidence Score: 52.6

Research Domains

Angiopoietin 2 has been studied across 17 research domains including 🔬 Oncology, 🫘 Kidney, ❤️ Cardiovascular, 🫁 Respiratory, 🔬 Inflammation. The primary research focus is 🔬 Oncology with 26% of studies addressing this area.

Loading evidence profile...

This evidence profile for Angiopoietin 2 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.